Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714439 | 0.96 | LCK (0.59) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL14590390 | 0.96 | LCK (0.59) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL714869 | 0.90 | LCK (0.76) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL10051136 | 0.90 | LCK (0.76) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL2425755 | 0.90 | LCK (0.68) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL13844443 | 0.87 | LCK (0.73) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL6858907 | 0.87 | LCK (0.52) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL146414 | 0.87 | LCK (0.52) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL15591979 | 0.87 | LCK (0.65) | LCKALDH1A1TDP1TSHRLOX | |
| SCHEMBL15591987 | 0.87 | LCK (0.65) | LCKALDH1A1TDP1TSHRLOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 967 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333375-A1 | CYANOCARBON COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-10-30 | — | — | US | claimed |
| US-12404235-B2 | Tricyanohexane purification methods | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-09-02 | — | — | US | claimed |
| US-12215070-B2 | Cyanocarbon compositions | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-02-04 | — | — | US | claimed |
| US-20240106002-A1 | ELECTROLYTE, ELECTROCHEMICAL APPARATUS, AND ELECTRONIC APPARATUS | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-03-28 | — | — | US | claimed |
| EP-4333150-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND ELECTRONIC DEVICE | Ningde Amperex Technology Limited (CN) | 2024-03-06 | — | — | EP | claimed |
| US-11780804-B2 | Tricyanohexane purification methods | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2023-10-10 | — | — | US | claimed |
| CN-116387617-A | Electrochemical device and electronic device including the same | 宁德新能源科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| EP-4085046-A1 | PROCESS FOR RECOVERING ADIPONITRILE | Ascend Performance Materials Operations LLC (US) | 2022-11-09 | — | — | EP | claimed |
| EP-4085045-A1 | PROCESS FOR SEPARATING TRICYANOHEXANE | Ascend Performance Materials Operations LLC (US) | 2022-11-09 | — | — | EP | claimed |
| WO-2022227450-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND ELECTRONIC DEVICE | 宁德新能源科技有限公司 | 2022-11-03 | — | — | WO | claimed |
| EP-2382241-B1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORP (JP) | 2016-11-23 | — | — | EP | claimed |
| US-8785566-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2014-07-22 | — | — | US | claimed |
| US-7776475-B2 | Lithium rechargeable battery and lithium rechargeable battery pack | SAMSUNG SDI CO., LTD. (KR) | 2010-08-17 | — | — | US | claimed |
| US-20060035144-A1 | Lithium rechargeable battery and lithium rechargeable battery pack | SAMSUNG SDI CO., LTD. (KR) | 2006-02-16 | — | — | US | claimed |
| US-6743564-B2 | A POSITIVE RESIST FORMULATION CONSISTS OF NITRILE CONTAINING TERT-AMINE COMPOUND, AN ORGANIC SOLVENT AND A BASE RESIN HAVING AN ACIDIC FUNCTIONAL GROUP WHICH IS PROTECTED WITH AN ACID LABILE GROUP, A PHOTOACID GENERATOR | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-06-01 | — | — | US | claimed |
| EP-0343597-B1 | PREPARATION OF TRIS (2-CYANOETHYL) AMINE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-03-03 | — | — | EP | claimed |
| EP-0343597-A1 | Preparation of tris (2-cyanoethyl) amine | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-11-29 | — | — | EP | claimed |
| US-4841092-A | Preparation of tris(2-cyanoethyl)amine | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-20 | — | — | US | claimed |
| US-4552705-A | REACTING ACRYLONITRILE AND AMMONIA IN A POLAR SOLVENT HAVING A HIGH DIELECTRIC CONSTANT | THE STANDARD OIL COMPANY (US) | 1985-11-12 | — | — | US | claimed |
| US-3972876-A | Process for the preparation of symmetrical and unsymmetrical azines and mixtures thereof | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1976-08-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215070-B2 | Cyanocarbon compositions | CYCS, CBR3, PCCA | LCK 1949/4885ALDH1A1 3668/4885TDP1 359/4885 |
| US-20250333375-A1 | CYANOCARBON COMPOSITIONS | CYCS, CBR3, PCCA | LCK 1949/4885ALDH1A1 3668/4885TDP1 359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.